• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.

作者信息

Teng Fei, Zhang Ju-Xiang, Chang Qi-Meng, Wu Xu-Bo, Tang Wei-Guo, Wang Jian-Fa, Feng Jin-Feng, Zhang Zi-Ping, Hu Zhi-Qiu

机构信息

Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University, Shanghai, 201199, People's Republic of China.

Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, 201199, People's Republic of China.

出版信息

J Exp Clin Cancer Res. 2020 Dec 9;39(1):277. doi: 10.1186/s13046-020-01780-y.

DOI:10.1186/s13046-020-01780-y
PMID:33298087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7724876/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0859/7724876/147ef7c7ace2/13046_2020_1780_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0859/7724876/e37514138860/13046_2020_1780_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0859/7724876/e48e27ae0123/13046_2020_1780_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0859/7724876/147ef7c7ace2/13046_2020_1780_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0859/7724876/e37514138860/13046_2020_1780_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0859/7724876/e48e27ae0123/13046_2020_1780_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0859/7724876/147ef7c7ace2/13046_2020_1780_Fig6_HTML.jpg

相似文献

1
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.对《长链非编码RNA MYLK-AS1通过靶向miR-424-5p/E2F7轴并激活血管内皮生长因子受体2信号通路促进肝癌肿瘤进展和血管生成》一文的修正
J Exp Clin Cancer Res. 2020 Dec 9;39(1):277. doi: 10.1186/s13046-020-01780-y.
2
Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma.更正：长链非编码RNA MYLK-AS1通过靶向miR-424-5p/E2F7轴并激活肝细胞癌中的VEGF R-2信号通路促进肿瘤进展和血管生成。
J Exp Clin Cancer Res. 2023 Sep 30;42(1):257. doi: 10.1186/s13046-023-02824-9.
3
A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.一种新型长链非编码 RNA MCM3AP-AS1 通过靶向 miR-194-5p/FOXA1 轴促进肝癌的生长。
Mol Cancer. 2019 Feb 19;18(1):28. doi: 10.1186/s12943-019-0957-7.
4
Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.长链非编码 RNA FOXD3-AS1 的抑制作用通过上调 miR-296-5p 并抑制 TGF-β1/Smads 信号通路抑制甲状腺癌细胞的侵袭和迁移。
Mol Cell Endocrinol. 2020 Jan 15;500:110634. doi: 10.1016/j.mce.2019.110634. Epub 2019 Oct 31.
5
LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR 相关通路调控前列腺癌细胞 DU-145 对阿霉素的耐药性。
IUBMB Life. 2019 Oct;71(10):1537-1551. doi: 10.1002/iub.2075. Epub 2019 Jun 12.
6
LncRNA LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer progression.长链非编码 RNA LOXL1-AS1/miR-28-5p/SEMA7A 轴促进胰腺癌进展。
Cell Biochem Funct. 2020 Jan;38(1):58-65. doi: 10.1002/cbf.3449. Epub 2019 Nov 15.
7
LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.长链非编码 RNA DBH-AS1 通过 FAK/Src/ERK 通路靶向 miR-138 促进肝癌的发生。
Biomed Pharmacother. 2018 Nov;107:824-833. doi: 10.1016/j.biopha.2018.08.079. Epub 2018 Aug 22.
8
LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis.长链非编码 RNA STXBP5-AS1 通过靶向 miR-96-5p/PTEN 轴抑制宫颈癌进展。
Biomed Pharmacother. 2019 Sep;117:109082. doi: 10.1016/j.biopha.2019.109082. Epub 2019 Jun 15.
9
lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.长链非编码 RNA A1BG-AS1 通过靶向 miR-216a-5p 抑制肝癌细胞的增殖和侵袭。
J Cell Biochem. 2019 Jun;120(6):10310-10322. doi: 10.1002/jcb.28315. Epub 2018 Dec 16.
10
Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.长链非编码 RNA SBF2-AS1 通过调控 miR-140-5p-TGFBR1 通路促进肝癌进展。
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2826-2832. doi: 10.1016/j.bbrc.2018.08.047. Epub 2018 Aug 14.

引用本文的文献

1
LncRNA MSTO2P affects the proliferation, invasion and migration of non-small cell lung cancer by regulating the Wnt/β-catenin pathway.长链非编码RNA MSTO2P通过调控Wnt/β-连环蛋白信号通路影响非小细胞肺癌的增殖、侵袭和迁移。
Discov Oncol. 2025 Feb 10;16(1):150. doi: 10.1007/s12672-025-01920-w.
2
The role of competing endogenous RNA network in the development of hepatocellular carcinoma: potential therapeutic targets.竞争性内源性RNA网络在肝细胞癌发生发展中的作用：潜在治疗靶点
Front Cell Dev Biol. 2024 Jan 31;12:1341999. doi: 10.3389/fcell.2024.1341999. eCollection 2024.
3
bestDEG: a web-based application automatically combines various tools to precisely predict differentially expressed genes (DEGs) from RNA-Seq data.

本文引用的文献

1
LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.长链非编码 RNA MYLK-AS1 通过靶向 miR-424-5p/E2F7 轴和激活血管内皮生长因子受体 2 信号通路促进肝癌的进展和血管生成。
J Exp Clin Cancer Res. 2020 Nov 9;39(1):235. doi: 10.1186/s13046-020-01739-z.
bestDEG：一个基于网络的应用程序，可以自动结合各种工具，从 RNA-Seq 数据中准确预测差异表达基因（DEGs）。
PeerJ. 2022 Nov 10;10:e14344. doi: 10.7717/peerj.14344. eCollection 2022.
4
The role of long non-coding RNAs in angiogenesis and anti-angiogenic therapy resistance in cancer.长链非编码RNA在癌症血管生成及抗血管生成治疗耐药中的作用
Mol Ther Nucleic Acids. 2022 Mar 15;28:397-407. doi: 10.1016/j.omtn.2022.03.012. eCollection 2022 Jun 14.
5
Long Non-Coding RNA LINC01572 Promotes Hepatocellular Carcinoma Progression Sponging miR-195-5p to Enhance PFKFB4-Mediated Glycolysis and PI3K/AKT Activation.长链非编码RNA LINC01572通过海绵吸附miR-195-5p促进肝细胞癌进展，增强PFKFB4介导的糖酵解和PI3K/AKT激活。
Front Cell Dev Biol. 2021 Dec 14;9:783088. doi: 10.3389/fcell.2021.783088. eCollection 2021.
6
LncRNA MYLK-AS1 acts as an oncogene by epigenetically silencing large tumor suppressor 2 (LATS2) in gastric cancer.长链非编码 RNA MYLK-AS1 通过表观遗传沉默胃癌中的大肿瘤抑制因子 2（LATS2）发挥癌基因作用。
Bioengineered. 2021 Dec;12(1):3101-3112. doi: 10.1080/21655979.2021.1944019.